- Home
- UONEK vs ANTX Comparison
UONEK vs ANTX Comparison
Compare UONEK & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- ANTX
- Stock Information
- Founded
- UONEK 1980
- ANTX 2017
- Country
- UONEK United States
- ANTX United States
- Employees
- UONEK N/A
- ANTX N/A
- Industry
- UONEK Broadcasting
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- UONEK Consumer Discretionary
- ANTX Health Care
- Exchange
- UONEK Nasdaq
- ANTX Nasdaq
- Market Cap
- UONEK 31.6M
- ANTX 33.2M
- IPO Year
- UONEK N/A
- ANTX 2022
- Fundamental
- Price
- UONEK $0.81
- ANTX $1.07
- Analyst Decision
- UONEK
- ANTX Buy
- Analyst Count
- UONEK 0
- ANTX 2
- Target Price
- UONEK N/A
- ANTX $2.00
- AVG Volume (30 Days)
- UONEK 185.5K
- ANTX 287.9K
- Earning Date
- UONEK 08-07-2025
- ANTX 08-12-2025
- Dividend Yield
- UONEK N/A
- ANTX N/A
- EPS Growth
- UONEK N/A
- ANTX N/A
- EPS
- UONEK N/A
- ANTX N/A
- Revenue
- UONEK $437,499,000.00
- ANTX N/A
- Revenue This Year
- UONEK N/A
- ANTX N/A
- Revenue Next Year
- UONEK N/A
- ANTX N/A
- P/E Ratio
- UONEK N/A
- ANTX N/A
- Revenue Growth
- UONEK N/A
- ANTX N/A
- 52 Week Low
- UONEK $0.44
- ANTX $0.87
- 52 Week High
- UONEK $1.57
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- UONEK 63.74
- ANTX 42.84
- Support Level
- UONEK $0.56
- ANTX $1.07
- Resistance Level
- UONEK $1.40
- ANTX $1.11
- Average True Range (ATR)
- UONEK 0.15
- ANTX 0.04
- MACD
- UONEK 0.01
- ANTX 0.00
- Stochastic Oscillator
- UONEK 29.76
- ANTX 7.14
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.